These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 21925220)

  • 1. Toxicology of nanoparticles.
    Elsaesser A; Howard CV
    Adv Drug Deliv Rev; 2012 Feb; 64(2):129-37. PubMed ID: 21925220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manufactured nanoparticles: an overview of their chemistry, interactions and potential environmental implications.
    Ju-Nam Y; Lead JR
    Sci Total Environ; 2008 Aug; 400(1-3):396-414. PubMed ID: 18715626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
    Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The devil is in the details (or the surface): impact of surface structure and surface energetics on understanding the behavior of nanomaterials in the environment.
    Mudunkotuwa IA; Grassian VH
    J Environ Monit; 2011 May; 13(5):1135-44. PubMed ID: 21523296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in assessing nanomaterial toxicology: a personal perspective.
    Geraci CL; Castranova V
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(6):569-77. PubMed ID: 20799267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles: a review of particle toxicology following inhalation exposure.
    Bakand S; Hayes A; Dechsakulthorn F
    Inhal Toxicol; 2012; 24(2):125-35. PubMed ID: 22260506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for nanoparticle surface reactivity in facilitating pulmonary toxicity and development of a base set of hazard assays as a component of nanoparticle risk management.
    Warheit DB; Reed KL; Sayes CM
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():61-7. PubMed ID: 19558235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks.
    Warheit DB; Sayes CM; Reed KL; Swain KA
    Pharmacol Ther; 2008 Oct; 120(1):35-42. PubMed ID: 18703086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of engineered nanoparticles with various components of the environment and possible strategies for their risk assessment.
    Bhatt I; Tripathi BN
    Chemosphere; 2011 Jan; 82(3):308-17. PubMed ID: 20980041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approach to using mechanism-based structure activity relationship (SAR) analysis to assess human health hazard potential of nanomaterials.
    Lai DY
    Food Chem Toxicol; 2015 Nov; 85():120-6. PubMed ID: 26111809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin, separation and identification of environmental nanoparticles: a review.
    Tsao TM; Chen YM; Wang MK
    J Environ Monit; 2011 May; 13(5):1156-63. PubMed ID: 21505694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do nanoparticles present ecotoxicological risks for the health of the aquatic environment?
    Moore MN
    Environ Int; 2006 Dec; 32(8):967-76. PubMed ID: 16859745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles: their potential toxicity, waste and environmental management.
    Bystrzejewska-Piotrowska G; Golimowski J; Urban PL
    Waste Manag; 2009 Sep; 29(9):2587-95. PubMed ID: 19427190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical methods to assess nanoparticle toxicity.
    Marquis BJ; Love SA; Braun KL; Haynes CL
    Analyst; 2009 Mar; 134(3):425-39. PubMed ID: 19238274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complexity of nanoparticle dissolution and its importance in nanotoxicological studies.
    Misra SK; Dybowska A; Berhanu D; Luoma SN; Valsami-Jones E
    Sci Total Environ; 2012 Nov; 438():225-32. PubMed ID: 23000548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormetic dose-responses in nanotechnology studies.
    Iavicoli I; Fontana L; Leso V; Calabrese EJ
    Sci Total Environ; 2014 Jul; 487():361-74. PubMed ID: 24793332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental implications of nanoparticle aging in the processing and fate of copper-based nanomaterials.
    Mudunkotuwa IA; Pettibone JM; Grassian VH
    Environ Sci Technol; 2012 Jul; 46(13):7001-10. PubMed ID: 22280489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential hazard of nanoparticles: from properties to biological and environmental effects.
    Kahru A; Savolainen K
    Toxicology; 2010 Mar; 269(2-3):89-91. PubMed ID: 20176073
    [No Abstract]   [Full Text] [Related]  

  • 20. Nanotoxicological classification system (NCS) - a guide for the risk-benefit assessment of nanoparticulate drug delivery systems.
    Keck CM; Müller RH
    Eur J Pharm Biopharm; 2013 Aug; 84(3):445-8. PubMed ID: 23333302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.